Team

Quentin Jacomet has over 15 years’ experience in growth capital with IDF Capital, Avenir Entreprises (now BPI France Investissement) and Turenne Capital. He has taken part in around 40 investments, particularly in healthcare, software and databases – particularly Capsule Tech – working actively alongside the managers of those companies.

Quentin coordinates Extens’ investment strategy.

After graduating from EM Lyon Business School, Quentin went on to earn a master’s degree in company law from Paris II University (Assas).

Arnaud Houette was president of CapsuleTech (data-collection software for hospitals) from 2004 to 2012. During that time, revenue grew from €1 million to €40 million in the United States, where the company became the market leader thanks to its strategic partnerships with major players such as Philips, GE and Siemens.

Arnaud coordinates the e-health market view and focuses on the investment and exit strategies.

After earning an engineering degree from AgroParisTech, Arnaud spent 12 years with Air Liquide, particularly in South East Asia, before taking the reins at CapsuleTech.

Charles Bourgain joined Extens in May 2022 as Investment Director, before being promoted to Executive Director at the end of 2024. He began his career in 2016 with Turenne Groupe as an analyst before being promoted to associate. He then joined Essling Capital in 2018.

Charles chaired France Invest Avenir from 2020 to 2022 and was a member of the France Invest Under 35 Board from 2021 to 2022.

Charles is an engineer from ENSEEIHT and a graduate from ESSEC Business School.

Morgane Decultieux joined Extens in January 2021 as an Analyst, before being promoted to Associate in January 2022, then Investment Director in May 2023, and finally Executive Director at the end of 2024. She began her career in 2017 at Mérieux Equity Partners as an analyst. She then worked in IQVIA's consulting division, and later at Wefight.

Morgane is also an Advisor to the Anne and Claude Berda Foundation since January 2023.

Morgane holds a PharmD from the University Claude Bernard Lyon 1 and an MSc in Finance from EM Lyon.

Aymeline Lecomte joined Extens in 2018 as CFO, with responsibility for the fund’s financial and administrative management. She began her career in audit at Ernst & Young, where she spent four years, before moving to Société Générale’s Group Finance Division in the Consolidation Department.

Aymeline is a graduate of HEC Paris.

Thomas Ploquin joined Extens in 2023 as Head of Investor Relations. He previously held various business development roles at Richelieu Finance, SCOR Investment Partners, and Essling Capital. He began his career at Thomson Financial, a global provider of software and data solutions for financial industry professionals.

Thomas holds a Master’s degree in International Finance from ESDES Lyon Business School.

Federico Miotto joined Extens in July 2019 as an analyst before being promoted to associate in January 2022.

Federico is a graduate of ESSEC Business School and the University of Trento in Italy.

Vincent Céré joined Extens in September 2022 as an analyst, following earlier experience in private equity at UI Investissement and an initial internship with Extens. He was promoted to Associate in 2024.

Vincent holds a Master’s degree in Corporate Finance from Toulouse School of Management.

Grace Bonazebi joined Extens in December 2022 after working in the hotel industry.

She ensures the smooth running of the office and assists the administrative and financial management. 

Grace holds a Certificate of Professional Qualification in Reception and Administration.

A long-time friend and partner at Extens, Dominique Mercier passed away on February 12 2023 after a year-long battle against illness.

Dominique Mercier had in-depth knowledge of the healthcare industry, medical devices, and hospital IT systems. He held managerial positions in the healthcare industry at W.L. Gore, Zimmer, Medtronic, Smith Medical, and Maquet. He also spent 12 years at Dräger Group, where he was president for France and Southern Europe. In 2013, he participated in a LBO to acquire Bow Medical, the French leader in software for anaesthesiologists and intensive-care units, in order to help the company expand in France and internationally.

His history with Extens goes back before its inception, in 2008 when Quentin Jacomet, Arnaud Houette, and Dominique Mercier joined forces at Capsule Technologies (a leading global provider of medical device integration, clinical surveillance, and patient monitoring for hospitals) as Investor, CEO, and Board Member, respectively.

Alexis Vandier has over 20 years’ experience in the Pharmaceutical Industry, Business Development and Strategy coupled with a deep understanding of the market trends. 

Jakub Crhonek is a longstanding Private Equity professional with expertise in Turnarounds and extensive network in the European software market, particularly in Switzerland and Germany. 

Philippe Gervais has a strong operational expertise in Homecare, Medical Assistance and Insurance industries, with prior international experiences in Private Equity, Strategy and Corporate M&A.

Mark Pel serves as Senior Advisor Benelux, where he focuses on deal origination across the region. He supports the firm in add-on acquisitions for existing portfolio companies as well as new platform opportunities.

Active in corporate finance and private equity since 2008, Mark has led a wide range of M&A transactions, including sell-side, buy-side, merger, and capital-raising assignments, primarily for private equity firms. He brings broad experience across sectors and deal types.

His relationship with Extens began in early 2024, when he advised the firm on its acquisition of Medicore, a leading Dutch provider of electronic health record (EHR) software for the mental healthcare market.

Mark holds a Master’s degree in Business Administration with a specialisation in Finance from the University of Groningen.